drugset / Trial / NCT03986008
Effects of Benaglutide on Weight and Gut Microbiota in Obese Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this studay is to evaluate the effects of Benaglutide on the treatment of subjects with obesity.
Timeline
- Start
- 2019-12-01
- Primary completion
- 2021-12-23
- Completion
- 2021-12-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Benaglutide | Unknown | 0.2 mg | Subcutaneous |
| Comparator | Liraglutide | Peptide | 1.8 mg | Subcutaneous |